Publicacións en colaboración con investigadores/as de National and Kapodistrian University of Athens (116)

2025

  1. A 5-transcript signature for discriminating viral and bacterial etiology in pediatric pneumonia

    iScience, Vol. 28, Núm. 2

  2. A diagnostic host-specific transcriptome response for Mycoplasma pneumoniae pneumonia to guide pediatric patient treatment

    Nature communications, Vol. 16, Núm. 1, pp. 673

  3. Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis

    Clinical Cancer Research, Vol. 31, Núm. 11, pp. 2196-2209

  4. From Better Diagnostics to Earlier Treatment: The Rapidly Evolving Alzheimer’s Disease Landscape

    Medicina (Lithuania), Vol. 61, Núm. 8

  5. Immunity to Streptococcus pyogenes and Common Respiratory Viruses at Age 0 to 4 Years after COVID-19 Restrictions

    JAMA Network Open, Vol. 8, Núm. 10

  6. Influence of body mass index on cardiovascular risk in rheumatoid arthritis varies across anti-citrullinated protein antibody status and biologic use

    RMD Open, Vol. 11, Núm. 2

  7. Procalcitonin use in febrile children attending European emergency departments: a prospective multicenter study

    BMC Pediatrics, Vol. 25, Núm. 1

  8. Prognostic Factors of Late-onset Hearing Loss in Infants With Congenital Cytomegalovirus and Normal Audiologic Assessment at Birth

    Pediatric Infectious Disease Journal

  9. Status of Sepsis Care in European Hospitals Results from an International Cross-Sectional Survey

    American Journal of Respiratory and Critical Care Medicine, Vol. 211, Núm. 4, pp. 587-599

2024

  1. Antiviral Treatment and Risk of Hearing Loss in Asymptomatic and Mild Symptomatic Infants With Congenital Cytomegalovirus

    Pediatric Infectious Disease Journal

  2. Biological use influences the impact of inflammation on risk of major adverse cardiovascular events in rheumatoid arthritis

    RMD Open, Vol. 10, Núm. 3

  3. European Society of Intensive Care Medicine guidelines on end of life and palliative care in the intensive care unit

    Intensive Care Medicine, Vol. 50, Núm. 11, pp. 1740-1766

  4. External validation of a multivariable prediction model for identification of pneumonia and other serious bacterial infections in febrile immunocompromised children

    Archives of Disease in Childhood, Vol. 109, Núm. 1, pp. 58-66

  5. Guidelines for minimal information on cellular senescence experimentation in vivo

    Cell, Vol. 187, Núm. 16, pp. 4150-4175

  6. Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children

    The Journal of experimental medicine, Vol. 221, Núm. 2

  7. Plasma Protein Biomarkers Distinguish Multisystem Inflammatory Syndrome in Children From Other Pediatric Infectious and Inflammatory Diseases

    The Pediatric infectious disease journal, Vol. 43, Núm. 5, pp. 444-453

  8. Prevalence and Phenotypic Susceptibility to Doravirine of the HIV-1 Reverse Transcriptase V106I Polymorphism in B and Non-B Subtypes

    Journal of Infectious Diseases, Vol. 229, Núm. 6, pp. 1796-1802

  9. Raising AWaRe-ness of Antimicrobial Stewardship Challenges in Pediatric Emergency Care: Results from the PERFORM Study Assessing Consistency and Appropriateness of Antibiotic Prescribing Across Europe

    Clinical Infectious Diseases, Vol. 78, Núm. 3, pp. 526-534

2023

  1. A European-Japanese study on peach allergy: IgE to Pru p 7 associates with severity

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 9, pp. 2497-2509

  2. A cross-country study on the impact of governmental responses to the COVID-19 pandemic on perinatal mental health

    Scientific Reports, Vol. 13, Núm. 1